Assessment of Clinical Effectiveness of BNT162b2 COVID-19 Vaccine in US Adolescents-Reference-Cited by-同舟云学术

Assessment of Clinical Effectiveness of BNT162b2 COVID-19 Vaccine in US Adolescents

Published:2022-03-03 Issue:3 Volume:5 Page:e220935
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Oliveira Carlos R.¹²,Niccolai Linda M.³,Sheikha Hassan¹,Elmansy Lina¹,Kalinich Chaney C.³,Grubaugh Nathan D.³⁴,Shapiro Eugene D.¹³,Billig Kendall⁵,Breban Mallery I.⁵,Brito Anderson⁵,Earnest Rebecca⁵,Fauver Joseph R.⁵,Koch Tobias⁵,Ott Isabel⁵,Petrone Mary⁵,Vogels Chantal B.F.⁵,Pham Kien⁵,Tikhonova Irina⁵,Castaldi Christopher⁵,Mane Shrikant⁵,Bilguvar Kaya⁵,De Kumar Bony⁵,Ferguson David⁵,Kerantzas Nicholas⁵,Landry Marie⁵,Peaper David⁵,Schulz Wade⁵,

Affiliation:

1. Department of Pediatrics, Section of Infectious Diseases and Global Health, Yale School of Medicine, New Haven, Connecticut

2. Department of Biostatistics, Section of Health Informatics, Yale School of Public Health, New Haven, Connecticut

3. Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut

4. Department of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut

5. for the Yale SARS-CoV-2 Genomic Surveillance Initiative

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2789579/oliveira_2022_oi_220051_1645640201.24422.pdf

Reference42 articles.

1. Hospitalizations associated with COVID-19 among children and adolescents—COVID-NET, 14 states, March 1, 2020-August 14, 2021.;Delahoy;MMWR Morb Mortal Wkly Rep,2021

2. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020.;Oliver;MMWR Morb Mortal Wkly Rep,2020

3. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12-15 years—United States, May 2021.;Wallace;MMWR Morb Mortal Wkly Rep,2021

4. Safety, immunogenicity, and efficacy of the BNT162b2 COVID-19 vaccine in adolescents.;Frenck;N Engl J Med,2021

5. Case-control studies to assess the effectiveness of vaccines.;Shapiro;J Pediatric Infect Dis Soc,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of Abdala COVID-19 subunit vaccine in children and adolescents: An open-label, single-arm, phase 2 trial (MEÑIQUE);Vaccine;2024-09

2. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis;Journal of the Pediatric Infectious Diseases Society;2024-05-23

3. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis;2024-01-18

4. Efficacy and Safety of COVID-19 Vaccines in Adolescents: Systematic Review of Randomized Controlled Studies and Observational Studies;Pediatric Infection & Vaccine;2024

5. Detection and Characterization of Web-Based Pediatric COVID-19 Vaccine Discussions and Racial and Ethnic Minority Topics: Retrospective Analysis of Twitter Data;JMIR Pediatrics and Parenting;2023-11-30